用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [IPC] 包含 'A'
  • [专利权人] 包含 'Wyeth'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页537 条记录, 当前第1/54页。
公开号 公开日 申请号 申请日
1. US8669273B2 2014/3/11
专利标题:Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine 法律状态
专利权人Wyeth;
A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272 SKI-606 EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens kits and methods for treatment of neoplasm including breast cancer including metastatic breast cancer and lung cancer using this combination optionally in combination with other anti-neoplastic agents or immune modulators are also described.


2. CA2539982C 2013/5/14 CA20042539982 2004/9/30
专利标题:Pantoprazole multiparticulate formulations 法律状态
专利权人Wyeth;
Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof or a salt thereof a surfactant and a distintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water an enteric coat on the sub-coat and a final seal coat over the enteric coat which is composed of hydroxypropyl methylcellulose (hypromellose) and water.


3. CA2602089C 2013/4/30
专利标题:Tigecycline compositions and methods of preparation 法律状态
专利权人Wyeth;
The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline a suitable carbohydrate and an acid or buffer.


4. MY147180A 2012/11/14 MY2004PI04005 2004/9/30
专利标题:Pantoprazole multiparticulate formulations 法律状态
专利权人Wyeth;
A METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE (GERD) ULCERS OF THE STOMACH OR DUODENUM OR ZOLLINGER-ELLISON SYNDROME IN A HUMAN BY ADMINISTERING PANTOPRAZOLE SODIUM MULTIPARTICULATES IS DESCRIBED. THE PANTOPRAZOLE MULTIPARTICULATES HAVE A SPHEROID CORE OF PANTOPRAZOLE OR AN ENANTIOMER THEREOF OR A SALT THEREOF A SURFACTANT AND A DISINTEGRANT; A SUB COAT WHICH IS COMPRISED OF HYDROXYPROPYL METHYLCELLULOSE (HYPROMELLOSE) AND WATER AN ENTERIC COAT ON THE SUBCOAT AND A FINAL SEAL COAT OVER TH...


5. CN101405031B 2012/10/10 CN20078009723 2007/8/3
专利标题:The formulation and its purposes that are used for the parenteral delivery chemical compound 法律状态
专利权人Wyeth;


6. MY146098A 2012/6/29 MY2004PI05049 2004/12/7
专利标题:Oxazole derivatives of tetracyclines 法律状态
专利权人Wyeth;
THIS INVENTION PROVIDES COMPOUNDS OF THE FORMULA: WHEREIN A" X AND Y ARE DEFINED IN THE SPECIFICATION. THESE COMPOUNDS ARE USEFUL AS ANTIBACTERIAL AGENTS.


7. US8163729B2 2012/4/24
专利标题:Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof 法律状态
专利权人Wyeth;
The present invention provides compounds of formula (I) and compositions thereof methods of making them and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders diseases and conditions. Provided compounds can affect among other things neurological psychiatric and/or inflammatory system.


8. AU2006223226B2 2012/3/15
专利标题:Tigecycline compositions and methods of preparation 法律状态
专利权人Wyeth;
The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline a suitable carbohydrate and an acid or buffer.


9. PL396568A1 2012/2/13
专利标题:Crystalline o-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline o-desmethyl-venlafaxine succinate 法律状态
专利权人Wyeth;


10. BRPI0620213A2 2011/11/1 BR2006PI20213 2006/12/19
专利标题:Método para preparar uma composição de rapamicina tendo potência aumentada. 法律状态
专利权人Wyeth;
MéTODO PARA PREPARAR UMA COMPOSIçãO DE RAPAMICINA TENDO POTêNCIA AUMENTADA é descrito um método para preparar uma composição de sirolimus com uma maior potência. O método envolve selecionar um composto de rapamicina que tem menos que 15% de impurezas de rapamicina oxidativas e hidrolíticas e formular a rapamicina selecionada com um antioxidante e excipientes opcionais.



首页123456下页尾页537 条记录, 当前第1/54页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文